155 related articles for article (PubMed ID: 9516910)
21. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
22. Persistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
[TBL] [Abstract][Full Text] [Related]
23. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
24. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
26. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
27. The search of the stool and blood K-ras mutations in patients with pancreatic mass.
Pezzilli R; Barassi A; Melzi d'Eril G; Fantini L; Pallotti F; Tomassetti P; Corinaldesi R
Pancreas; 2006 Aug; 33(2):199-200. PubMed ID: 16868489
[No Abstract] [Full Text] [Related]
28. [K-ras gene mutation in gallbladder carcinoma].
Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
[TBL] [Abstract][Full Text] [Related]
29. Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy.
Kimura T; Holland WS; Kawaguchi T; Williamson SK; Chansky K; Crowley JJ; Doroshow JH; Lenz HJ; Gandara DR; Gumerlock PH
Ann N Y Acad Sci; 2004 Jun; 1022():55-60. PubMed ID: 15251940
[TBL] [Abstract][Full Text] [Related]
30. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
31. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
[TBL] [Abstract][Full Text] [Related]
32. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R
Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
[TBL] [Abstract][Full Text] [Related]
34. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
35. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations.
Gansauge S; Schmid RM; Muller J; Adler G; Mattfeldt T; Beger HG
Br J Surg; 1998 Mar; 85(3):337-40. PubMed ID: 9529487
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis.
Brentnall TA; Chen R; Lee JG; Kimmey MB; Bronner MP; Haggitt RC; Kowdley KV; Hecker LM; Byrd DR
Cancer Res; 1995 Oct; 55(19):4264-7. PubMed ID: 7671233
[TBL] [Abstract][Full Text] [Related]
38. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool.
Mulcahy H; Farthing MJ
Ann Oncol; 1999; 10 Suppl 4():114-7. PubMed ID: 10436800
[TBL] [Abstract][Full Text] [Related]
40. Soluble normal and mutated DNA sequences from single-copy genes in human blood.
Sorenson GD; Pribish DM; Valone FH; Memoli VA; Bzik DJ; Yao SL
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):67-71. PubMed ID: 8118388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
